Immunotherapy Combination Effective Against Chemotherapy-Resistant Breast Cancer – Specialty Pharmacy Times
|
Immunotherapy Combination Effective Against Chemotherapy-Resistant Breast Cancer
Specialty Pharmacy Times The results of an early clinical trial suggest that the addition of an immunotherapy to a treatment regimen may be able to overcome chemotherapy-resistance in patients with breast cancer. The combination of pembrolizumab (Keytruda) plus trastuzumab … |
